Tegretol and Saphris drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tegretol (carbamazepine) and Saphris (asenapine maleate). Common drug interactions include movement disorder among females and withdrawal syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Tegretol and Saphris. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.
What is Tegretol?
Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 45,969 Tegretol users. Check the latest studies of Tegretol.
What is Saphris?
Saphris has active ingredients of asenapine maleate. It is often used in bipolar i disorder. eHealthMe is studying from 8,688 Saphris users. Check the latest studies of Saphris.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
81 people who take Tegretol and Saphris together, and have interactions are studied.

What are the common drug interactions of Tegretol and Saphris, by gender? *:
female:
- Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Pseudodementia (severe form of depression that results from a progressive brain disorder in which cognitive changes mimic those of dementia)
- Sleep disorder
- Suicide attempt
- Toothache (tooth pain)
- Weight decreased
- Death
- Dysgeusia (disorder of the sense of taste)
- Gingival pain (gum pain)
male:
- Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
- Back disorder
- Cat scratch disease (bacterial infection by cat scratch)
- Coma (state of unconsciousness lasting more than six hours)
- Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
- Dyskinesia (abnormality or impairment of voluntary movement)
- Hyposmia (impairment of the sense of smell)
- Increased appetite
- Nephrolithiasis (calculi in the kidneys)
- Neuralgia (pain in one or more nerves)
What are the common drug interactions of Tegretol and Saphris, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
- Sedation
20-29:
- Back pain
- Cat scratch disease (bacterial infection by cat scratch)
- Coma (state of unconsciousness lasting more than six hours)
- Constipation
- Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
- Drug ineffective
- Dyskinesia (abnormality or impairment of voluntary movement)
- Hyposmia (impairment of the sense of smell)
- Impaired gastric emptying
- Increased appetite
30-39:
- Partial seizures (seizures which affect only a part of the brain at onset)
- Rash generalised (rash on most of body parts)
- Rash pruritic (redness with itching)
- Sedation
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Tendon injury
- Throat tightness
- Tooth discolouration (a change in colour of teeth)
- Visual impairment
40-49:
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Fatigue (feeling of tiredness)
- Foot fracture
- Fungal infection
- Insomnia (sleeplessness)
- Nausea (feeling of having an urge to vomit)
- Pruritus generalised (generalized itching)
- Urinary retention (the inability to completely or partially empty the bladder)
- Vision blurred
- Vomiting
50-59:
- Disturbance in attention
- Confusional state
- Vision blurred
- Fall
- Back disorder
- Dysstasia (difficulty in standing)
- Fatigue (feeling of tiredness)
- Pain
- Rash
- Road traffic accident
60+:
- Dizziness
- Abdominal discomfort
- Gait disturbance
- Heart rate decreased
- Hospitalisation
- Intervertebral disc protrusion (spinal disc protrusion)
- Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Pharyngeal disorder
- Psoriasis (immune-mediated disease that affects the skin)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 30 people, 37.04%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 29 people, 35.80%
- Insomnia (sleeplessness): 14 people, 17.28%
- Bipolar Disorder (mood disorder): 12 people, 14.81%
- Stress And Anxiety: 8 people, 9.88%
- Pain: 8 people, 9.88%
- Sleep Disorder: 6 people, 7.41%
- Drowsiness: 6 people, 7.41%
- Depression: 5 people, 6.17%
* Approximation only. Some reports may have incomplete information.
Do you take Tegretol and Saphris?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tegretol and Saphris:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tegretol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Saphris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tegretol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Saphris and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on carbamazepine and asenapine maleate (the active ingredients of Tegretol and Saphris, respectively), and Tegretol and Saphris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Naprosyn and Garlic - 3 seconds ago
- Could Trikafta cause Tinnitus? - 3 seconds ago
- Could Entyvio cause Arrhythmias? - 5 seconds ago
- Could Venlafaxine Hydrochloride cause Photophobia Aggravated? - 6 seconds ago
- Could Povidone Iodine cause Hypokalemia? - 11 seconds ago
- Could Nimodipine cause Back Pain? - 11 seconds ago
- Could Biaxin cause Dyshidrotic Eczema? - 14 seconds ago
- Could Cod Liver Oil cause Nasal Congestion? - 19 seconds ago
- Could Tecfidera cause Hiatal Hernia? - 21 seconds ago
- Could Venlafaxine Hydrochloride cause Pollakiuria? - 26 seconds ago